Hubert W.
- Country
- Germany
- Department
- #200; Klinik und Poliklinik für Onkologie, Gastroenterologie, Hepatologie und Pneumologie
Research Overview
- A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Admilparant in Participants with Idiopathic Pulmonary Fibrosis
- A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Admilparant in Participants with Progressive Pulmonary Fibrosis
- Phase IIb Randomized, Placebo‑Controlled Study of Oral AZD8965 on Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis
Data & Insights
Has run more than one trial at 257 of 462 partner sites.
Specializations
Pulmonary Arterial Hypertension
This investigator specializes in pulmonary arterial hypertension (PAH) therapeutic research, evaluating novel treatment approaches for patients with progressive disease. Their research encompasses the assessment of various therapeutic agents including sotatercept, KER-012, and ralinepag in combination with background PAH therapies.
- Long-term PAH Treatment Evaluation
- Combination Therapy Assessment
- Disease Progression Management
Pulmonary Fibrosis Research
The investigator conducts extensive research in idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis. Their work involves evaluating innovative treatments including bexotegrast and novel compounds for improving lung function and managing IPF-related symptoms.
- IPF Treatment Development
- Lung Function Assessment
- Cough Management in IPF
Lung Cancer Treatment
The investigator focuses on advanced treatment approaches for non-small cell lung cancer (NSCLC), including research on ALK-positive NSCLC. Their work encompasses both early-stage and metastatic disease, investigating combinations of immunotherapy with conventional treatments.
- Perioperative Therapy Development
- Targeted Treatment Strategies
- Combined Therapeutic Approaches
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.